LYNPARZA
LYNPARZA
Discontinued
DIN Number
02454408
Drug Class
Human
Market Date
May 16, 2016
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02454408
AIG Number0158110001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XK01 OLAPARIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
OLAPARIBActive
Strength: 50 MG
Monograph: OLAPARIB